Salim Yusuf

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

Salim Yusuf, Steven Hawken, Stephanie Ôunpuu et al. · The Lancet · 2004 · 12K citations · Full text

Medicine, Cardiology, Internal Medicine +15

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text

Medicine, Cardiology, Pharmacotherapy +12

Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study

Martin O’Donnell, Denis Xavier, Lisheng Liu et al. · The Lancet · 2010 · 3.5K citations

Medicine, Neurology, Risk Assessment +10

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Medicine, Pharmacology, Pharmacotherapy +10

Beta blockade during and after myocardial infarction: An overview of the randomized trials

Salim Yusuf, Richard Peto, John A. Lewis et al. · Progress in Cardiovascular Diseases · 1985 · 3.2K citations

Medicine, Cardiology, Pharmacology +15